• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环 miR-130 及其靶标 PPAR-γ 可能是 2 型糖尿病合并冠心病患者的潜在生物标志物。

Circulating miR-130 and its target PPAR-γ may be potential biomarkers in patients of coronary artery disease with type 2 diabetes mellitus.

机构信息

Department of Cardiology, Cangzhou Central Hospital, Cangzhou, Hebei, China.

出版信息

Mol Genet Genomic Med. 2019 Sep;7(9):e909. doi: 10.1002/mgg3.909. Epub 2019 Aug 1.

DOI:10.1002/mgg3.909
PMID:31368668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6732310/
Abstract

BACKGROUND

Patients of coronary artery disease (CAD) with type 2 diabetes mellitus (DM2) show increased mortality risk than CAD patients without DM2, while few biomarkers can be used to discriminate them.

METHODS

Fifty-nine patients of CAD with DM2 (DM2-CAD group), 79 patients of CAD without DM2 (CAD group), and 63 healthy control subjects were recruited. Circulating miR-130 (miR-130a and miR-130b) and PPAR-γ (peroxisome proliferator-activated receptor gamma) were measured and their Pearson correlation was analyzed. 3' UTR binding prediction and luciferase assay were used to determine the target relationship between miR-130 and PPAR-γ. Receiver operating characteristics (ROC) analysis was performed to test the discrimination ability of miR-130 between DM2-CAD and CAD groups.

RESULTS

miR-130a and miR-130b showed decreased expression in DM2-CAD group when compared with the CAD group and health control. Both bioinformatics and luciferase assays showed that miR-130 could bind the 3' UTR of PPAR-γ. Furthermore, miR-130 negatively correlated with PPAR-γ in both CAD and DM2-CAD group in Pearson's coefficient analysis. Both miR-130a and miR-130b were able to discriminate DM2-CAD group from CAD group and control subjects.

CONCLUSION

Circulating miR-130 may regulate the expression of PPAR-γ and can be used as a biomarker to discriminate DM2-CAD from CAD.

摘要

背景

患有 2 型糖尿病(DM2)的冠心病(CAD)患者的死亡率高于无 DM2 的 CAD 患者,但很少有生物标志物可用于区分他们。

方法

招募了 59 例 CAD 合并 DM2 患者(DM2-CAD 组)、79 例 CAD 无 DM2 患者(CAD 组)和 63 例健康对照者。检测循环 miR-130(miR-130a 和 miR-130b)和过氧化物酶体增殖物激活受体γ(peroxisome proliferator-activated receptor gamma,PPAR-γ),并分析其 Pearson 相关性。利用 3'UTR 结合预测和荧光素酶测定来确定 miR-130 与 PPAR-γ 的靶关系。进行受试者工作特征(receiver operating characteristic,ROC)分析以测试 miR-130 在 DM2-CAD 与 CAD 组之间的区分能力。

结果

与 CAD 组和健康对照组相比,DM2-CAD 组 miR-130a 和 miR-130b 的表达降低。生物信息学和荧光素酶测定均显示 miR-130 可与 PPAR-γ 的 3'UTR 结合。此外,Pearson 相关系数分析显示,在 CAD 组和 DM2-CAD 组中,miR-130 与 PPAR-γ 呈负相关。miR-130a 和 miR-130b 均能区分 DM2-CAD 组与 CAD 组和对照组。

结论

循环 miR-130 可能调节 PPAR-γ 的表达,可作为一种生物标志物用于区分 DM2-CAD 与 CAD。

相似文献

1
Circulating miR-130 and its target PPAR-γ may be potential biomarkers in patients of coronary artery disease with type 2 diabetes mellitus.循环 miR-130 及其靶标 PPAR-γ 可能是 2 型糖尿病合并冠心病患者的潜在生物标志物。
Mol Genet Genomic Med. 2019 Sep;7(9):e909. doi: 10.1002/mgg3.909. Epub 2019 Aug 1.
2
Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients.循环中富含内皮细胞的微小RNA-126作为2型糖尿病患者冠状动脉疾病的潜在生物标志物。
Biomarkers. 2017 May-Jun;22(3-4):268-278. doi: 10.1080/1354750X.2016.1204004. Epub 2016 Jul 11.
3
Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease.循环微小RNA-126和微小RNA-210作为2型糖尿病合并冠状动脉疾病生物标志物的潜在价值。
Br J Biomed Sci. 2018 Apr;75(2):82-87. doi: 10.1080/09674845.2017.1402404. Epub 2018 Feb 16.
4
Circulating miR-30c as a predictive biomarker of type 2 diabetes mellitus with coronary heart disease by regulating PAI-1/VN interactions.循环 miR-30c 通过调节 PAI-1/VN 相互作用作为 2 型糖尿病伴冠心病的预测生物标志物。
Life Sci. 2019 Dec 15;239:117092. doi: 10.1016/j.lfs.2019.117092. Epub 2019 Nov 21.
5
Upregulation of Circulating Cardiomyocyte-Enriched miR-1 and miR-133 Associate with the Risk of Coronary Artery Disease in Type 2 Diabetes Patients and Serve as Potential Biomarkers.循环心肌细胞高表达的 miR-1 和 miR-133 与 2 型糖尿病患者的冠心病风险相关,并可作为潜在的生物标志物。
J Cardiovasc Transl Res. 2019 Aug;12(4):347-357. doi: 10.1007/s12265-018-9857-2. Epub 2019 Jan 4.
6
Clinical Value of Circulating Microribonucleic Acids miR-1 and miR-21 in Evaluating the Diagnosis of Acute Heart Failure in Asymptomatic Type 2 Diabetic Patients.循环微小核糖核酸 miR-1 和 miR-21 在评估无症状 2 型糖尿病患者急性心力衰竭诊断中的临床价值。
Biomolecules. 2019 May 17;9(5):193. doi: 10.3390/biom9050193.
7
Type 2 diabetes is associated with decreased PGC1α expression in epicardial adipose tissue of patients with coronary artery disease.2型糖尿病与冠心病患者心外膜脂肪组织中PGC1α表达降低有关。
J Transl Med. 2016 Aug 19;14(1):243. doi: 10.1186/s12967-016-0999-1.
8
Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes.血小板衍生的miR-103b作为2型糖尿病早期诊断的新型生物标志物。
Acta Diabetol. 2015 Oct;52(5):943-9. doi: 10.1007/s00592-015-0733-0. Epub 2015 Mar 29.
9
Biochemical investigation of rs1801282 variations in PPAR-γ gene and its correlation with risk factors of diabetes mellitus in coronary artery disease.对 PPAR-γ 基因 rs1801282 变异的生化研究及其与冠心病糖尿病危险因素的相关性。
Clin Exp Pharmacol Physiol. 2020 Sep;47(9):1517-1529. doi: 10.1111/1440-1681.13339. Epub 2020 May 31.
10
Circulating miR-103 family as potential biomarkers for type 2 diabetes through targeting CAV-1 and SFRP4.循环 miR-103 家族通过靶向 CAV-1 和 SFRP4 作为 2 型糖尿病的潜在生物标志物。
Acta Diabetol. 2020 Mar;57(3):309-322. doi: 10.1007/s00592-019-01430-6. Epub 2019 Oct 3.

引用本文的文献

1
Mechanistic insight into the role of cardiac-enriched microRNAs in diabetic heart injury.对心脏富集微小RNA在糖尿病性心脏损伤中作用的机制性洞察。
Am J Physiol Heart Circ Physiol. 2025 Apr 1;328(4):H865-H884. doi: 10.1152/ajpheart.00736.2024. Epub 2025 Mar 4.
2
Specific muscle targeted delivery of miR-130a loaded lipid nanoparticles: a novel approach to inhibit lipid accumulation in skeletal muscle and obesity.靶向特定肌肉递送负载miR-130a的脂质纳米颗粒:一种抑制骨骼肌脂质积累和肥胖的新方法。
J Nanobiotechnology. 2025 Mar 3;23(1):159. doi: 10.1186/s12951-025-03225-0.
3
Interplay of NF-κB and PPAR-γ transcription factors in patients with juvenile systemic lupus erythematosus.

本文引用的文献

1
Treatment of PAH with a PPARγ agonist.用PPARγ激动剂治疗肺动脉高压。
Nat Rev Cardiol. 2018 Jul;15(7):381. doi: 10.1038/s41569-018-0029-5.
2
Defining a conformational ensemble that directs activation of PPARγ.定义一个构象集合,指导 PPARγ 的激活。
Nat Commun. 2018 May 4;9(1):1794. doi: 10.1038/s41467-018-04176-x.
3
Predictive value of coronary computed tomography angiography in asymptomatic individuals with diabetes mellitus: Systematic review and meta-analysis.冠状动脉计算机断层血管造影在无症状糖尿病患者中的预测价值:系统评价和荟萃分析。
青少年系统性红斑狼疮患者中核因子-κB与过氧化物酶体增殖物激活受体-γ转录因子的相互作用
Lupus Sci Med. 2025 Jan 8;12(1):e001263. doi: 10.1136/lupus-2024-001263.
4
Glycemia-Induced miRNA Changes: A Review.血糖诱导的 miRNA 变化:综述。
Int J Mol Sci. 2023 Apr 19;24(8):7488. doi: 10.3390/ijms24087488.
5
Circulating miRNA as potential biomarkers for diabetes mellitus type 2: should we focus on searching for sex differences?循环 miRNA 作为 2 型糖尿病的潜在生物标志物:我们是否应该专注于寻找性别差异?
J Appl Genet. 2022 May;63(2):293-303. doi: 10.1007/s13353-021-00678-5. Epub 2022 Jan 5.
6
Identification and Characterization of Circulating MicroRNAs as Novel Biomarkers in Dogs With Heart Diseases.循环微小RNA作为犬类心脏病新型生物标志物的鉴定与特征分析
Front Vet Sci. 2021 Oct 11;8:729929. doi: 10.3389/fvets.2021.729929. eCollection 2021.
7
miR‑130b regulates PTEN to activate the PI3K/Akt signaling pathway and attenuate oxidative stress‑induced injury in diabetic encephalopathy.miR-130b 通过调控 PTEN 激活 PI3K/Akt 信号通路减轻糖尿病脑病氧化应激损伤
Int J Mol Med. 2021 Jul;48(1). doi: 10.3892/ijmm.2021.4974. Epub 2021 Jun 3.
8
and the Volatile of Attenuate Chronic Myocardial Ischemia Injury in a Pig Model: A Metabonomic Approach for the Mechanism Study.用代谢组学方法研究挥发性成分减轻猪慢性心肌缺血损伤的作用机制
Oxid Med Cell Longev. 2021 Apr 28;2021:8840896. doi: 10.1155/2021/8840896. eCollection 2021.
9
miR-720 Regulates Insulin Secretion by Targeting Rab35.miR-720 通过靶向 Rab35 调节胰岛素分泌。
Biomed Res Int. 2021 Apr 5;2021:6662612. doi: 10.1155/2021/6662612. eCollection 2021.
10
Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary Fibrosis.循环编码和长非编码 RNA 作为特发性肺纤维化的潜在生物标志物。
Int J Mol Sci. 2020 Nov 20;21(22):8812. doi: 10.3390/ijms21228812.
J Cardiovasc Comput Tomogr. 2018 Jul-Aug;12(4):320-328. doi: 10.1016/j.jcct.2018.04.002. Epub 2018 Apr 12.
4
Kinetics of Circulating MicroRNAs in Response to Cardiac Stress in Patients With Coronary Artery Disease.冠状动脉疾病患者循环微小RNA对心脏应激反应的动力学
J Am Heart Assoc. 2017 Jul 27;6(8):e005270. doi: 10.1161/JAHA.116.005270.
5
Predictive Effects of Circulating miR-221, miR-130a and miR-155 for Coronary Heart Disease: A Multi-Ethnic Study in China.循环miR-221、miR-130a和miR-155对冠心病的预测作用:中国多民族研究
Cell Physiol Biochem. 2017;42(2):808-823. doi: 10.1159/000478071. Epub 2017 Jun 19.
6
Association Between Coronary Artery Disease and MicroRNA: Literature Review and Clinical Perspective.冠状动脉疾病与微小RNA之间的关联:文献综述与临床展望
Cureus. 2017 Apr 23;9(4):e1188. doi: 10.7759/cureus.1188.
7
MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ.微小RNA-130b通过抑制过氧化物酶体增殖物激活受体γ来减轻M2巨噬细胞极化,从而促进糖尿病小鼠肥胖相关的脂肪组织炎症和胰岛素抵抗。
Immunol Lett. 2016 Dec;180:1-8. doi: 10.1016/j.imlet.2016.10.004. Epub 2016 Oct 13.
8
Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.过氧化物酶体增殖物激活受体α、δ和γ基因多态性与冠心病风险的关联:一项病例对照研究及荟萃分析
Medicine (Baltimore). 2016 Aug;95(32):e4299. doi: 10.1097/MD.0000000000004299.
9
Association of the PPARγ2 Pro12Ala polymorphism with increased risk of cardiovascular diseases.PPARγ2基因Pro12Ala多态性与心血管疾病风险增加的关联。
Genet Mol Res. 2015 Dec 29;14(4):18662-74. doi: 10.4238/2015.December.28.15.
10
Relationship between thioredoxin-interacting protein (TXNIP) and islet β-cell dysfunction in patients with impaired glucose tolerance and hypertriglyceridemia.葡萄糖耐量受损和高甘油三酯血症患者中硫氧还蛋白相互作用蛋白(TXNIP)与胰岛β细胞功能障碍的关系。
Int J Clin Exp Med. 2015 Mar 15;8(3):4363-8. eCollection 2015.